Peter Kampmann
Copenhagen, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Etranacogene dezaparvovec in people with hemophilia B and without adeno-associated virus serotype 5 neutralizing antibodies: a 4-year subgroup analysis of the Health Outcomes with Padua Gene; Evaluation in Hemophilia B (HOPE-B) trial.
Journal: Research and practice in thrombosis and haemostasis
Published: August 31, 2025
Mobile computed tomography at the Munich Oktoberfest : From idea to implementation.
Journal: Radiologie (Heidelberg, Germany)
Published: October 04, 2024
Low vitamin C status and hypermobility-related disorders in patients with bleeding disorder of unknown cause.
Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: July 15, 2024
Invasive procedures and surgery following etranacogene dezaparvovec gene therapy in people with hemophilia B.
Journal: Journal of thrombosis and haemostasis : JTH
Published: April 04, 2024
Inspection and maintenance of industrial infrastructure with autonomous underwater robots.
Journal: Frontiers in robotics and AI
Published: June 15, 2023
Infrastructural considerations of implementing gene therapy for hemophilia in the Nordic context.
Journal: Therapeutic advances in hematology
Published: April 05, 2023
Gene Therapy with Etranacogene Dezaparvovec for Hemophilia B.
Journal: The New England journal of medicine
Published: February 22, 2023
Prostatic artery embolization in men with severe hemophilia a: a case report of two patients.
Journal: CVIR endovascular
Published: February 02, 2022
A national Danish proof of concept on feasibility and safety of home -based intensive chemotherapy in patients with acute myeloid leukemia.
Journal: Leukemia research
Published: August 31, 2021
SARS-CoV-2 vaccine-induced immune thrombosis and thrombocytopenia
Journal: Ugeskrift for laeger
Published: August 06, 2021
Last Updated: 09/26/2026